Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $83.4 million.

  • Ingevity's Cash & Equivalents fell 3845.02% to $83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.4 million, marking a year-over-year decrease of 3845.02%. This contributed to the annual value of $68.0 million for FY2024, which is 2909.28% down from last year.
  • Ingevity's Cash & Equivalents amounted to $83.4 million in Q3 2025, which was down 3845.02% from $76.9 million recorded in Q2 2025.
  • In the past 5 years, Ingevity's Cash & Equivalents registered a high of $275.4 million during Q4 2021, and its lowest value of $68.0 million during Q2 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $88.5 million (2024), whereas its average is $130.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 7316.26% in 2022, then skyrocketed by 6035.5% in 2024.
  • Ingevity's Cash & Equivalents (Quarter) stood at $275.4 million in 2021, then tumbled by 72.15% to $76.7 million in 2022, then grew by 25.03% to $95.9 million in 2023, then dropped by 29.09% to $68.0 million in 2024, then increased by 22.65% to $83.4 million in 2025.
  • Its Cash & Equivalents stands at $83.4 million for Q3 2025, versus $76.9 million for Q2 2025 and $71.5 million for Q1 2025.